A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia
Conditions: Gestational Trophoblastic Disease; Gestational Trophoblastic Neoplasia; Gestational Trophoblastic Tumor, Recurrent Intervention: Drug: Pembrolizumab Sponsors: Imperial College London; Cancer Research UK Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials